OBJECTIVE: Mitochondrial function plays a role in both AIDS progression and HAART toxicity; therefore, we sought to determine whether mitochondrial DNA variation revealed novel AIDS restriction genes, particularly as mitochondrial DNA single-nucleotide polymorphisms are known to influence regulation of oxidative phosphorylation, reactive oxygen species production, and apoptosis. DESIGN: This is a retrospective cohort study. METHODS: We performed an association study of mitochondrial DNA haplogroups among 1833 European American HIV-1 patients from five US cohorts: the Multicenter AIDS Cohort Study, the San Francisco City Clinic Study, Hemophilia Growth and Development Study, the Multicenter Hemophilia Cohort Study, and the AIDS Linked to Intravenous Experiences cohort to determine whether the mitochondrial DNA haplogroup correlated with AIDS progression rate. RESULTS: Mitochondrial DNA haplogroups J and U5a were elevated among HIV-1 infected people who display accelerated progression to AIDS and death. Haplogroups Uk, H3, and IWX appeared to be highly protective against AIDS progression. CONCLUSION: The associations found in our study appear to support a functional explanation by which mitochondrial DNA variation among haplogroups, influencing ATP production, reactive oxygen species generation, and apoptosis, is correlated to AIDS disease progression; however, repeating these results in cohorts with different ethnic backgrounds would be informative. These data suggest that mitochondrial genes are important indicators of AIDS disease progression in HIV-1 infected persons.
OBJECTIVE: Mitochondrial function plays a role in both AIDS progression and HAART toxicity; therefore, we sought to determine whether mitochondrial DNA variation revealed novel AIDS restriction genes, particularly as mitochondrial DNA single-nucleotide polymorphisms are known to influence regulation of oxidative phosphorylation, reactive oxygen species production, and apoptosis. DESIGN: This is a retrospective cohort study. METHODS: We performed an association study of mitochondrial DNA haplogroups among 1833 European American HIV-1patients from five US cohorts: the Multicenter AIDS Cohort Study, the San Francisco City Clinic Study, Hemophilia Growth and Development Study, the Multicenter Hemophilia Cohort Study, and the AIDS Linked to Intravenous Experiences cohort to determine whether the mitochondrial DNA haplogroup correlated with AIDS progression rate. RESULTS: Mitochondrial DNA haplogroups J and U5a were elevated among HIV-1 infected people who display accelerated progression to AIDS and death. Haplogroups Uk, H3, and IWX appeared to be highly protective against AIDS progression. CONCLUSION: The associations found in our study appear to support a functional explanation by which mitochondrial DNA variation among haplogroups, influencing ATP production, reactive oxygen species generation, and apoptosis, is correlated to AIDS disease progression; however, repeating these results in cohorts with different ethnic backgrounds would be informative. These data suggest that mitochondrial genes are important indicators of AIDS disease progression in HIV-1 infectedpersons.
Authors: D Genini; D Sheeter; S Rought; J J Zaunders; S A Susin; G Kroemer; D D Richman; D A Carson; J Corbeil; L M Leoni Journal: FASEB J Date: 2000-11-09 Impact factor: 5.191
Authors: Eduardo Ruiz-Pesini; Dan Mishmar; Martin Brandon; Vincent Procaccio; Douglas C Wallace Journal: Science Date: 2004-01-09 Impact factor: 47.728
Authors: Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich Journal: Nat Genet Date: 2006-07-23 Impact factor: 38.330
Authors: S Moretti; S Marcellini; A Boschini; G Famularo; G Santini; E Alesse; S M Steinberg; M G Cifone; G Kroemer; C De Simone Journal: Clin Exp Immunol Date: 2000-12 Impact factor: 4.330
Authors: M W Hilgartner; S M Donfield; A Willoughby; C F Contant; B L Evatt; E D Gomperts; W K Hoots; J Jason; K A Loveland; S M McKinlay Journal: Am J Pediatr Hematol Oncol Date: 1993-05
Authors: Ryszard Olinski; Daniel Gackowski; Marek Foksinski; Rafal Rozalski; Krzysztof Roszkowski; Pawel Jaruga Journal: Free Radic Biol Med Date: 2002-07-15 Impact factor: 7.376
Authors: Anita Lakatos; Olga Derbeneva; Danny Younes; David Keator; Trygve Bakken; Maria Lvova; Marty Brandon; Guia Guffanti; Dora Reglodi; Andrew Saykin; Michael Weiner; Fabio Macciardi; Nicholas Schork; Douglas C Wallace; Steven G Potkin Journal: Neurobiol Aging Date: 2010-06-11 Impact factor: 4.673
Authors: Monique D Courtenay; John R Gilbert; Lan Jiang; Anna C Cummings; Paul J Gallins; Laura Caywood; Lori Reinhart-Mercer; Denise Fuzzell; Claire Knebusch; Renee Laux; Jacob L McCauley; Charles E Jackson; Margaret A Pericak-Vance; Jonathan L Haines; William K Scott Journal: Hum Genet Date: 2011-07-13 Impact factor: 4.132
Authors: Brahim Aissani; Sadeep Shrestha; Howard W Wiener; Jianming Tang; Richard A Kaslow; Craig M Wilson Journal: AIDS Date: 2014-08-24 Impact factor: 4.177
Authors: Phumla Z Sinxadi; Joel A Dave; David C Samuels; Jeannine M Heckmann; Gary Maartens; Naomi S Levitt; C William Wester; David W Haas; Todd Hulgan Journal: AIDS Res Hum Retroviruses Date: 2013-03-15 Impact factor: 2.205
Authors: Sher L Hendrickson; James A Lautenberger; Leslie Wei Chinn; Michael Malasky; Efe Sezgin; Lawrence A Kingsley; James J Goedert; Gregory D Kirk; Edward D Gomperts; Susan P Buchbinder; Jennifer L Troyer; Stephen J O'Brien Journal: PLoS One Date: 2010-09-21 Impact factor: 3.240
Authors: Aleksandra Klemba; Magdalena Kowalewska; Wojciech Kukwa; Katarzyna Tonska; Aleksandra Szybinska; Malgorzata Mossakowska; Anna Scinska; Paweł Golik; Kamil Koper; Jakub Radziszewski; Andrzej Kukwa; Anna M Czarnecka; Ewa Bartnik Journal: J Biomed Sci Date: 2010-09-08 Impact factor: 8.410
Authors: Anna M Czarnecka; Aleksandra Klemba; Andrzej Semczuk; Katarzyna Plak; Barbara Marzec; Tomasz Krawczyk; Barbara Kofler; Pawel Golik; Ewa Bartnik Journal: Int Arch Med Date: 2009-10-28